Foreign investors gain access to omnibus accounts, while Geely reports first-half 142 million-unit sales
The government expanded 7 month 8 day foreign investors’ access to omnibus accounts. On the same day, D&D Pharmatech launched a clinical 2 trial of a contrast agent, and the IMF raised Korea’s growth rate for 2026 to 2.6%. Geely announced global first-half sales of 142 million units, while the Bank of Korea detected 41 counterfeit banknotes in the first half.
The government announced that it had expanded foreign investors’ access to omnibus accounts on 2026 year 7 month 8 day. The system was improved so that foreign investors can trade domestic stocks and bonds more easily through a single account.
D&D Pharmatech’s global technology-transfer partner announced that it had begun a clinical trial of a contrast agent on 7 month 8 day. The company informed investors that the clinical trial had begun.2:
The International Monetary Fund (IMF) presented its forecast for Korea’s annual growth rate in 2026 at 2.6%. The IMF lowered its overall global outlook but raised its forecast for Korea.
Geely Group announced that in the first half of 2026its global sales totaled 142million units. The company said this figure was the highest level ever recorded.
Geely Group disclosed that it expanded sales and operations in the domestic market even while excluded from subsidy eligibility. The company added that there was an impact related to subsidy policies in certain markets.
The Bank of Korea reported that it detected 2026counterfeit banknotes in the first half of 41. This was 21fewer than in the same period a year earlier.
All of these disclosures were simultaneously released or filed on 2026 of 7 at 8. It is necessary to check for additional disclosures from the relevant companies and indicators.